Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

Summary

Previous studies showed that a dose of 8 millicuries of Altropane was appropriate for imaging patients with suspected Parkinson's disease. This study determined if a lower dose (5 millicuries) would suffice.

Timeline

Start

2023-04-24

Primary completion

2024-06-08

Completion

2024-06-08

Outcome

Outcome not reported

Stopped (Business): “Business Decision”

Drugs

Indications